Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 1057 - 1064 of 12127 results

Further Updates to the CPPA Proposed Regulations: Risk Assessments and Automated Decisionmaking Technology
March 25, 2024| Blog| Viewpoint

The Plan Sponsor's Guide to Drug Formularies and Prior Authorizations
March 25, 2024| News

Mintz Sees Revenue Hit All-Time High
March 25, 2024| News

Q&A with Guests from the Mintz’s Health Law Diagnosed Podcast Episode, Emerging Role of AI in Health Care
March 25, 2024| Blog| Viewpoint

Health Law Diagnosed – Women Leaders in Health Care: The Emerging Role of AI in Health Care
March 22, 2024| Podcast| Viewpoint

Energy & Sustainability Washington Update — April 2024
March 22, 2024| News

EPA Requires Industrial Sites to Plan for Pollution from Floods
March 22, 2024| News

FTC Chair Khan: “We Need to Choose Competition over National Champions” in the AI Age — AI: The Washington Report
March 21, 2024| Article| Viewpoint
News & Press Releases
Three Mintz Attorneys Recognized in Lawdragon’s 2025 500 Leading Global Real Estate Lawyers
September 11, 2025
Mintz members Daniel Guggenheim, Rebecca Lee, and Jeffrey Moerdler have been recognized by Lawdragon in its 2025 500 Leading Global Real Estate Lawyers list. The three attorneys were also recognized in last year’s inaugural edition of the list.
Mintz Recognized in LMG’s “Life Sciences Americas Awards” 2025
September 08, 2025
Mintz received a pair of awards at LMG’s 2025 “Life Sciences Americas Awards” which recognize the region’s “most distinguished practitioners and their firms for their exemplary work in the Life Sciences legal practice over the past twelve months.”
Why Masimo’s ‘Rare’ Move Pushes Apple Case Into Uncharted Territory
September 3, 2025
World Intellectual Property Review and Life Sciences Intellectual Property Review featured insights from Intellectual Property Division Chair Michael Renaud about Masimo’s decision to sue US Customs and Border Protection (CBP), the latest development in its legal battle with Apple. The article notes that it’s uncommon for a patent owner to sue CBP, which is backed by the US International Trade Commission (ITC), and that the results of this action may determine whether patent owners will still be able to rely on exclusion orders as enforcement tools in the future.
Events
Podcasts

Mintz On Air: Practical Policies – Disparage Me Not
August 26, 2025| Podcast|

Mintz On Air: Practical Policies - Investigations Unscripted
August 12, 2025| Podcast|

Mintz On Air: Practical Policies — A Private Equity Non-Compete Primer
July 15, 2025| Podcast|
